Vertex's Price Pop by the Numbers: Does It Fly?
Shares of Vertex Pharmaceuticals rise 40% on positive test results
Lululemon: What's Founder Chip Wilson Up To?
Founder Chip Wilson tries to shake things up at Lululemon
Twitter Could Be Gunning to Hit New Highs
Twitter has long-term potential, but for now it makes sense to lock in some profits.
Jason Haver: Long Bond Captures Target; S&P Approaches Its Next Targets
The bond-target capture leaves that playing field open; meanwhile equities are approaching their next targets.
Why Hercules Offshore, Merrimack Pharmaceuticals, and Smith & Wesson Holdings Tumbled Today
Even though the stock market climbed to new heights, these stocks missed out. Find out why.
Twitter's Bet on Social Television: Is It Enough?
Twitter acquires television editing platform SnappyTV.
Record Stock Buybacks and Dividend Payouts Fuel Equity Markets
Almost $1 trillion in cash was pushed back into the equity market in the first quarter.
Amazon Could Sell Off on Smartphone Introduction
The stock is likely to decline in the absence of a blockbuster product.